REKLAMA

SOPHARMA AD: Publication of materials for holding an Extraordinary General Meeting of Shareholders of “Sopharma” AD, scheduled for 15 January 2027

2026-11-18 16:40
publikacja
2026-11-18 16:40
Dodaj Bankier.pl w Google
Spis treści:
1. REPORT
2. ESAP METADATE
3. INFORMATION ABOUT THE ENTITY
4. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. SFA_EGM_15012027_EN.zip

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No

303

/

2026

Date of issue:

2026-11-18

Short name of the issuer

SOPHARMA AD

Subject

Publication of materials for holding an Extraordinary General Meeting of Shareholders of “Sopharma” AD, scheduled for 15 January 2027

Official market - legal basis

Art. 56 ust. 1 pkt 2 Ustawy o ofercie – informacje bieї№ce i okresowe

Unofficial market - legal basis

Contents of the report:

Sofia, Bulgaria, November 18, 2026 - According to the requirements of Art. 100t of the Law on Public Offering of Securities the Board of directors of “Sopharma” AD (SFA: “BSE“ AD, SPH: Warsaw Stock Exchange) presents the following materials on the agenda of EGM convened for January 15, 2027 and in the absence of a quorum on this date – for February 05, 2027, to the attention of shareholders, which will be available on the website of Extri News (www.x3news.com), in the FSC system, on the Company's website www.sopharmagroup.com and on the website www.investor.bg, as well as in hard copy at the address of the Company:

Annexes

File

Description

SFA_EGM_15012027_EN.zip

Publication of materials for holding an Extraordinary General Meeting of Shareholders of “Sopharma” AD, scheduled for 15 January 2027

Legal framework

Type of information

TRANSD

Inside information

RegulatoryData

Collection Body

PLKNF

Unique data record identifier

Type of submission

New (to be used for new information)

Voluntary information flag

Date or period covered [Date or beginning of the period to which the information relates]

2027-01-15

Date or period covered [Date or end of the period to which the information relates]

2027-01-15

Personal data flag

Macierzyste państwo członkowskie, w stosownych przypadkach

PL

DocumentReference

Język, w którym przekazano informacje

Oryginał (ORIG) czy tłumaczenie (TRAN)

Numer referencyjny pliku danych

PL

ORIG

SubmittingEntity

Submitting entity LEI

or

Submitting entity name - natural person

RelatedEntity/LegalPerson

Entity LEI

Size of the entity

Industry sector(s)

097900BGGW0000048796

Large undertaking

(acc. NACE): C

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD

Farmaceutyczny (far)

(short name of the issuer)

(sector according to clasification

of the WSE in Warsow)

1220

Sofia

(post code)

(city)

IlienskoShosse

16

(street)

(number)

+359 2 813 42 00

+359 2 936 02 86

(phone number)

(fax)

(e-mail)

(web site)

nd

(NIP)

(REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Date

Name

Position / Function

Signature

2026-11-18

Ognian Ivanov Donev

Executive Director

Najlepsze produkty finansowe znajdziesz w naszej porównywarce - SPRAWDŹ
Źródło:Komunikaty spółek (ESPI)
Tematy
Energooszczędny dom lub mieszkanie? Bank Millennium ma teraz ciekawą propozycję
Energooszczędny dom lub mieszkanie? Bank Millennium ma teraz ciekawą propozycję

Komentarze (0)

dodaj komentarz

Powiązane:

Polecane

Najnowsze

Popularne

Ważne linki